The promise and challenges of rare cancer research

Affiliations

¹ Department of Medicine, Columbia University Medical Center, 177 Ft Washington Avenue, Milstein 6-435, New York, NY 10032, USA.
² Department of Medicine, Columbia University Medical Center, 177 Ft Washington Avenue, Milstein 6-435, New York, NY 10032, USA. Electronic address: carvajalr@columbia.edu.

Comment

Kimberly M Komatsubara et al. Lancet Oncol. 2016 Feb.

. 2016 Feb;17(2):136-138.

doi: 10.1016/S1470-2045(15)00485-4.

¹ Department of Medicine, Columbia University Medical Center, 177 Ft Washington Avenue, Milstein 6-435, New York, NY 10032, USA.
² Department of Medicine, Columbia University Medical Center, 177 Ft Washington Avenue, Milstein 6-435, New York, NY 10032, USA. Electronic address: carvajalr@columbia.edu.

No abstract available

Comment on

Rare cancers: a sea of opportunity.
Boyd N, Dancey JE, Gilks CB, Huntsman DG. Boyd N, et al. Lancet Oncol. 2016 Feb;17(2):e52-e61. doi: 10.1016/S1470-2045(15)00386-1. Lancet Oncol. 2016. PMID: 26868354 Review.
The value of research collaborations and consortia in rare cancers.
Blay JY, Coindre JM, Ducimetière F, Ray-Coquard I. Blay JY, et al. Lancet Oncol. 2016 Feb;17(2):e62-e69. doi: 10.1016/S1470-2045(15)00388-5. Lancet Oncol. 2016. PMID: 26868355 Review.
Research methods to change clinical practice for patients with rare cancers.
Billingham L, Malottki K, Steven N. Billingham L, et al. Lancet Oncol. 2016 Feb;17(2):e70-e80. doi: 10.1016/S1470-2045(15)00396-4. Lancet Oncol. 2016. PMID: 26868356 Review.